SCHEMBL20133857

SCHEMBL20133857

COc1ccccc1N1CCC(NC(=O)OC(C)(C)C)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 10/20 0.60
CKS1B P61024 1/20 0.54
SKP1 P63208 1/20 0.54
SKP2 Q13309 1/20 0.54
CACNB4 O00305 1/20 0.53
CACNA1A O00555 1/20 0.53
CACNA1G O43497 1/20 0.53
CACNG3 O60359 1/20 0.53
CACNA1F O60840 1/20 0.53
CACNA1H O95180 1/20 0.53
CACNB3 P54284 1/20 0.53
CACNA2D1 P54289 1/20 0.53
CACNG7 P62955 1/20 0.53
CACNA1B Q00975 1/20 0.53
CACNA1D Q01668 1/20 0.53
CACNB1 Q02641 1/20 0.53
CACNG1 Q06432 1/20 0.53
CACNB2 Q08289 1/20 0.53
CACNA1S Q13698 1/20 0.53
CACNA1C Q13936 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17384450 0.94 PIM1 (0.59) DRD2CKS1BSKP1SKP2CACNB4
SCHEMBL34463006 0.89 DRD2 (0.58) DRD2CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL20129729 0.87 CKS1B (0.52) DRD2CKS1BSKP1SKP2PIM1
SCHEMBL20129730 0.86 CKS1B (0.51) DRD2CKS1BSKP1SKP2PIM1
SCHEMBL7716782 0.85 DRD2 (0.69) DRD2DRD3
SCHEMBL20149913 0.84 SUV39H2 (0.48) CKS1BSKP1SKP2CACNB4CACNA1A
SCHEMBL26484666 0.84 SUV39H2 (0.50) CKS1BSKP1SKP2SUV39H2
SCHEMBL20140998 0.84 MCOLN2 (0.55) DRD2DRD3MCOLN2MCOLN1MEN1
SCHEMBL1271996 0.84 CKS1B (0.55) DRD2CKS1BSKP1SKP2PIM1
SCHEMBL19284706 0.82 CKS1B (0.57) DRD2CKS1BSKP1SKP2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2020-07-02 US disclosed
EP-3538091-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF Navitor Pharmaceuticals, Inc. (US) 2019-09-18 EP disclosed
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2019-09-17 US disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR DRD2 3229/4885CKS1B 2986/4885SKP1 1767/4885
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR DRD2 3229/4885CKS1B 2986/4885SKP1 1767/4885
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR DRD2 3229/4885CKS1B 2986/4885SKP1 1767/4885
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR DRD2 3229/4885CKS1B 2986/4885SKP1 1767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.